DE3152363T1 - - Google Patents

Info

Publication number
DE3152363T1
DE3152363T1 DE19813152363 DE3152363T DE3152363T1 DE 3152363 T1 DE3152363 T1 DE 3152363T1 DE 19813152363 DE19813152363 DE 19813152363 DE 3152363 T DE3152363 T DE 3152363T DE 3152363 T1 DE3152363 T1 DE 3152363T1
Authority
DE
Germany
Prior art keywords
mercaptoacyl
oath
rehearsal
amino acid
antihypertensive agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19813152363
Other languages
English (en)
Other versions
DE3152363C2 (de
Inventor
Tadashi Iso
Hideyasu Yamauchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of DE3152363T1 publication Critical patent/DE3152363T1/de
Application granted granted Critical
Publication of DE3152363C2 publication Critical patent/DE3152363C2/de
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Description

Leerseite

Claims (1)

  1. Patentanspruch
    Antihypertensives Mittel, umfassend N-(Mercaptoacyl^aminosäure' und Probeneeid.
DE3152363T 1980-09-20 1981-09-18 Arzneimittel auf der Grundlage antihypertensiver N-(Mercaptoacyl)-aminosäuren und pharmazeutischer Hilfsstoffe Expired DE3152363C2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55131348A JPS5756425A (en) 1980-09-20 1980-09-20 Hypotensor

Publications (2)

Publication Number Publication Date
DE3152363T1 true DE3152363T1 (de) 1982-10-07
DE3152363C2 DE3152363C2 (de) 1985-11-21

Family

ID=15055826

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3152363T Expired DE3152363C2 (de) 1980-09-20 1981-09-18 Arzneimittel auf der Grundlage antihypertensiver N-(Mercaptoacyl)-aminosäuren und pharmazeutischer Hilfsstoffe

Country Status (9)

Country Link
US (1) US4424228A (de)
JP (1) JPS5756425A (de)
BE (1) BE890398A (de)
DE (1) DE3152363C2 (de)
FR (1) FR2490490A1 (de)
GB (1) GB2100127B (de)
IT (1) IT1139452B (de)
SE (1) SE8203054L (de)
WO (1) WO1982000954A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4483861A (en) * 1978-10-31 1984-11-20 Santen Pharmaceutical Co., Ltd. Antihypertensive sulfur-containing compounds
US5318985A (en) * 1991-12-20 1994-06-07 Merrell Dow Pharmaceuticals Inc. Potentiation of NMDA antagonists
JPH072567Y2 (ja) * 1992-01-28 1995-01-25 眞佐子 飯田 乳幼児用バスローブ
JPH06339749A (ja) * 1993-06-01 1994-12-13 Nippon Yakin Kogyo Co Ltd 高窒素含有ステンレス鋼線の製造方法及び製造装置
KR100362963B1 (ko) * 1997-08-27 2003-02-05 김성진 프로베네시드를유효성분으로하는항고혈압제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU528115B2 (en) * 1978-04-08 1983-04-14 Santen Pharmaceutical Co. Ltd. Antihypertensive 4-thiazolidine/carboxylic acids
JPS54148783A (en) * 1978-04-25 1979-11-21 Santen Pharmaceutical Co Ltd Thiazolidine derivative
JPS54135768A (en) * 1978-04-08 1979-10-22 Santen Pharmaceutical Co Ltd Thiazolidine derivative

Also Published As

Publication number Publication date
FR2490490B1 (de) 1984-05-25
US4424228A (en) 1984-01-03
BE890398A (fr) 1982-01-18
GB2100127B (en) 1984-08-01
JPS5756425A (en) 1982-04-05
IT8124047A0 (it) 1981-09-18
FR2490490A1 (fr) 1982-03-26
IT1139452B (it) 1986-09-24
WO1982000954A1 (en) 1982-04-01
JPS6213923B2 (de) 1987-03-30
SE8203054L (sv) 1982-05-14
DE3152363C2 (de) 1985-11-21
GB2100127A (en) 1982-12-22

Similar Documents

Publication Publication Date Title
DE3585575D1 (de) Blutstillendes mittel.
DE3579364D1 (de) Mittel zur speicherung und verteilung von waerme.
NL194155B (nl) Luchtzuiveringsinrichting.
FI861210A0 (fi) N,n'-dialkylguanidinodipeptider.
DE3778287D1 (de) Peptidische zusammensetzung.
DE3776261D1 (de) Naehrstoffzusammensetzung.
NL970030I2 (nl) N-(aminoalkylfenyl)sulfonamiden, de bereiding daarvan en de therapeutische toepassing daarvan.
FI853853L (fi) Kalander, t.ex. superkalander.
ES544787A0 (es) Preparaciones medicinales solidas
DE3787657D1 (de) Aminosäure-Derivate.
DE267674T1 (de) Zusammensetzungen zur verhinderung von inkrustierungen und deren verwendungen.
DK224985D0 (da) Peptider, og midler indeholdende peptiderne
ATE41773T1 (de) 4,5-dihydro-4-oxo-2((2-transphenylcyclopropyl)amino>-3-furancarbonsaeuren und derivate davon.
DE3582728D1 (de) Tertiaere aminoverbindungen.
ATE29881T1 (de) 4-hydroxy-2h-1-benzothiopyran-derivate, deren herstellungen und verwendungen.
DE3579915D1 (de) Antineoplastisches mittel.
DE3152363T1 (de)
DE3769843D1 (de) Mittel zur verhinderung von krustungsbildung.
DE3683006D1 (de) Kautschukmodifizierte polyamidzusammensetzung.
TR23713A (tr) Suebstituye edilmis tiouereler,izotiouereler ve korbadiimetiller
DE3575448D1 (de) Zange und zangenanordnung.
NO862662L (no) Haarkondisjoneringspreparat og fremgangsmaate for kondisjonering av haar.
ATE74912T1 (de) 2,2'-bi-1h-imidazole.
FI865244A0 (fi) Foerfarande foer framstaellning av optiskt aktiva 2-klor-12-(3-dimetylamino-2-metylpropyl)-12h-dibenzo-/d,g//1,3,6/ dioxazociner.
DE3884798T2 (de) Tripeptide von N-3-4-Methoxyfumaryl-L-2,3-diamino-propansäure und Methode zu deren Herstellung.

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: ZUMSTEIN SEN., F., DR. ASSMANN, E., DIPL.-CHEM. DR

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee